Literature DB >> 28096265

Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy.

Caroline Sibilla1, Anne Bertolotti1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating and rapidly progressive neurodegenerative disease caused by the deterioration of motor neurons. The first symptoms of ALS always begin at a focal but variable site and consistently spread to neighboring regions, suggesting that neurodegeneration in ALS is an orderly and propagating process. Like other neurodegenerative diseases, misfolding of a specific protein is central to ALS. SOD1, the major constituent of the protein deposits in some familial and sporadic forms of ALS, propagates its misfolded conformation like prions, providing a plausible molecular basis for the focality and spreading of muscle weakness in ALS. Because protein misfolding is a common cause of diverse neurodegenerative diseases, strategies aimed at boosting a cell's ability to cope with misfolded proteins could lead to therapeutics to combat these devastating age-related proteinopathies.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28096265      PMCID: PMC5630002          DOI: 10.1101/cshperspect.a024141

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  57 in total

Review 1.  How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?

Authors:  Bryan F Shaw; Joan Selverstone Valentine
Journal:  Trends Biochem Sci       Date:  2007-01-05       Impact factor: 13.807

2.  Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

Authors:  M D Kane; W J Lipinski; M J Callahan; F Bian; R A Durham; R D Schwarz; A E Roher; L C Walker
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

Review 4.  Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis.

Authors:  Joan Selverstone Valentine; Peter A Doucette; Soshanna Zittin Potter
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

5.  Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.

Authors:  Melanie Meyer-Luehmann; Janaky Coomaraswamy; Tristan Bolmont; Stephan Kaeser; Claudia Schaefer; Ellen Kilger; Anton Neuenschwander; Dorothee Abramowski; Peter Frey; Anneliese L Jaton; Jean-Marie Vigouret; Paolo Paganetti; Dominic M Walsh; Paul M Mathews; Jorge Ghiso; Matthias Staufenbiel; Lary C Walker; Mathias Jucker
Journal:  Science       Date:  2006-09-22       Impact factor: 47.728

6.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

Authors:  J A Johnston; M J Dalton; M E Gurney; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Different species of alpha-synuclein oligomers induce calcium influx and seeding.

Authors:  Karin M Danzer; Dorothea Haasen; Anne R Karow; Simon Moussaud; Matthias Habeck; Armin Giese; Hans Kretzschmar; Bastian Hengerer; Marcus Kostka
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

8.  The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress: elucidation by GADD34-deficient mice.

Authors:  Eiji Kojima; Akihide Takeuchi; Masataka Haneda; Ayako Yagi; Tadao Hasegawa; Ken-ichi Yamaki; Kiyoshi Takeda; Shizuo Akira; Kaoru Shimokata; Ken-ichi Isobe
Journal:  FASEB J       Date:  2003-06-03       Impact factor: 5.191

9.  Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha.

Authors:  I Novoa; H Zeng; H P Harding; D Ron
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

10.  Inhibition of a constitutive translation initiation factor 2alpha phosphatase, CReP, promotes survival of stressed cells.

Authors:  Céline Jousse; Seiichi Oyadomari; Isabel Novoa; Phoebe Lu; Yuhong Zhang; Heather P Harding; David Ron
Journal:  J Cell Biol       Date:  2003-11-24       Impact factor: 10.539

View more
  7 in total

Review 1.  Biological Spectrum of Amyotrophic Lateral Sclerosis Prions.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

2.  Prion-like protein aggregates exploit the RHO GTPase to cofilin-1 signaling pathway to enter cells.

Authors:  Zhen Zhong; Laura Grasso; Caroline Sibilla; Tim J Stevens; Nicholas Barry; Anne Bertolotti
Journal:  EMBO J       Date:  2018-03-01       Impact factor: 11.598

3.  Phosphorylated and aggregated TDP-43 with seeding properties are induced upon mutant Huntingtin (mHtt) polyglutamine expression in human cellular models.

Authors:  Laurent Coudert; Takashi Nonaka; Emilien Bernard; Masato Hasegawa; Laurent Schaeffer; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2019-03-12       Impact factor: 9.261

Review 4.  Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis.

Authors:  Deborah Ferrara; Laura Pasetto; Valentina Bonetto; Manuela Basso
Journal:  Front Neurosci       Date:  2018-08-17       Impact factor: 4.677

5.  Cytoplasmic Restriction of Mutated SOD1 Impairs the DNA Repair Process in Spinal Cord Neurons.

Authors:  Jiaojie Li; Miyoung Song; Sanghyun Moh; Heemin Kim; Dae-Hwan Kim
Journal:  Cells       Date:  2019-11-23       Impact factor: 6.600

Review 6.  Extracellular Vesicles as Innovative Tool for Diagnosis, Regeneration and Protection against Neurological Damage.

Authors:  Pavle Andjus; Maja Kosanović; Katarina Milićević; Mukesh Gautam; Seppo J Vainio; Denis Jagečić; Elena N Kozlova; Augustas Pivoriūnas; Juan-Carlos Chachques; Mirena Sakaj; Giulia Brunello; Dinko Mitrecic; Barbara Zavan
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

Review 7.  Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disorders.

Authors:  María Laura Palumbo; Alejandro David Moroni; Sofía Quiroga; María Micaela Castro; Adriana Laura Burgueño; Ana María Genaro
Journal:  Pharmacol Res Perspect       Date:  2021-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.